However, the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis, and Musculoskeletal Diseases (ESCEO) recommends pharmaceutical-grade prescription glucosamine for osteoarthritis (7), but the Society recommends against combining glucosamine with chondroitin and states that chondroitin may interfere with glucosamine absorption.